AMVGX | VMVIX | AMVGX / VMVIX | |
Total Expense Ratio | 0.78 | 0.19 | 411% |
Annual Report Gross Expense Ratio | 0.78 | 0.19 | 411% |
Fund Existence | 8 years | 19 years | - |
Gain YTD | 7.015 | 5.522 | 127% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7.09B | 30.6B | 23% |
Annual Yield % from dividends | 1.76 | 2.14 | 82% |
Returns for 1 year | 3.13 | 9.75 | 32% |
Returns for 3 years | 9.88 | 28.14 | 35% |
Returns for 5 years | 22.00 | 71.74 | 31% |
Returns for 10 years | N/A | 93.04 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
NSMVX | 40.91 | 0.27 | +0.66% |
North Star Micro Cap I | |||
AFYDX | 55.86 | 0.29 | +0.52% |
American Century Large Cap Equity Y | |||
DYGAX | 14.82 | 0.04 | +0.27% |
Meeder Dynamic Allocation Adviser | |||
ETAHX | 33.72 | -0.01 | -0.03% |
Eventide Healthcare & Life Sciences A | |||
FEPUX | 61.46 | -0.32 | -0.52% |
American Funds EUPAC 529-F-3 |